Skip to main content

Table 3 Facilitators and barriers to the management of PE/E using MgSO4 by type of facility

From: Factors influencing the use of magnesium sulphate in pre-eclampsia/eclampsia management in health facilities in Northern Nigeria: a mixed methods study

Item

Hospitals (n = 20), %

Health centers (n = 60), %

Total (n = 80), %

Facilitators

   

Attendance of a training on PE/E by SP

60

38.3

43.8

Identification of MgSO4 as first line drug by SP

85

58

65

Availability of service registers in the facility

80

58.3

63.7

Barriers

   

Non-availability of MgSO4

   

  Reported by SP

15

46.7

38.8

  Facility inventory

35

63.4

56.2

MgSO4 stockout§ in the facilitya

46

33

40

Non-availability of clinical guidelines/protocols in the facility

50

90

80

No supportive supervision received by SP

55

90

81.2

  1. aAmong those that had MgSO4 on the day of survey, N = 35
  2. p-value < 0.05
  3. §Events where supplies were completely exhausted before re-supply
  4. Routine supervisory visits by States’ Ministry of Health officials during which service providers are mentored and provided with technical assistance to improve on their work